Taro Pharmaceutical Industries Ltd (NYSE:TARO)

161.48
Data as of Aug 22
 +6.87 / +4.44%
Today’s Change
64.19
Today|||52-Week Range
161.93
+63.28%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Pharmaceuticals: Generic
MARKET CAP
$6.9B

Company Description

Taro Pharmaceutical Industries Ltd. engages in the development, manufacturing, and marketing of prescription and over-the-counter pharmaceutical products. Its products include topical creams, ointments, liquid, capsule, and tablet medications. It also involves in manufacturing and marketing of active drug ingredients for dermatological, cardiovascular and central nervous system therapeutic categories. The company was founded in 1950 and is headquartered in Haifa Bay, Israel.

Contact Information

Taro Pharmaceutical Industries Ltd.
14 Hakitor Street
Haifa Bay -- 26110
P:(724) 847-5700
Investor Relations:

Employees

Shareholders

Other institutional9.56%
Individual stakeholders10.58%
Mutual fund holders1.37%

Top Executives

Kal SundaramChief Executive Officer & Director
Michael KalbChief Financial & Accounting Officer, Group VP
Sharon AdlerVice President-Finance
Tzvi TalVice President-Information Technology
Avi AvramoffGlobal Vice President-Research & Development

To view my watchlist

Not a member yet?

Sign up now for a free account
Market indexes are shown in real time, except for the DJIA, which is delayed by two minutes. All times are ET. Disclaimer Morningstar: © 2014 Morningstar, Inc. All Rights Reserved. Disclaimer The Dow Jones IndexesSM are proprietary to and distributed by Dow Jones & Company, Inc. and have been licensed for use. All content of the Dow Jones IndexesSM © 2014 is proprietary to Dow Jones & Company, Inc. Chicago Mercantile Association. The market data is the property of Chicago Mercantile Exchange Inc. and its licensors. All rights reserved. FactSet Research Systems Inc. 2014. All rights reserved. Most stock quote data provided by BATS.